Literature DB >> 21574173

Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.

Michael K Connolly1, Diego Ayo, Ashim Malhotra, Michael Hackman, Andrea S Bedrosian, Junaid Ibrahim, Napoleon E Cieza-Rubio, Andrew H Nguyen, Justin R Henning, Monica Dorvil-Castro, H Leon Pachter, George Miller.   

Abstract

UNLABELLED: Acetaminophen (APAP) overdose is one of the most frequent causes of acute liver failure in the United States and is primarily mediated by toxic metabolites that accumulate in the liver upon depletion of glutathione stores. However, cells of the innate immune system, including natural killer (NK) cells, neutrophils, and Kupffer cells, have also been implicated in the centrilobular liver necrosis associated with APAP. We have recently shown that dendritic cells (DCs) regulate intrahepatic inflammation in chronic liver disease and, therefore, postulated that DC may also modulate the hepatotoxic effects of APAP. We found that DC immune-phenotype was markedly altered after APAP challenge. In particular, liver DC expressed higher MHC II, costimulatory molecules, and Toll-like receptors, and produced higher interleukin (IL)-6, macrophage chemoattractant protein-1 (MCP-1), and tumor necrosis factor alpha (TNF-α). Conversely, spleen DC were unaltered. However, APAP-induced centrilobular necrosis, and its associated mortality, was markedly exacerbated upon DC depletion. Conversely, endogenous DC expansion using FMS-like tyrosine kinase 3 ligand (Flt3L) protected mice from APAP injury. Our mechanistic studies showed that APAP liver DC had the particular capacity to prevent NK cell activation and induced neutrophil apoptosis. Nevertheless, the exacerbated hepatic injury in DC-depleted mice challenged with APAP was independent of NK cells and neutrophils or numerous immune modulatory cytokines and chemokines.
CONCLUSION: Taken together, these data indicate that liver DC protect against APAP toxicity, whereas their depletion is associated with exacerbated hepatotoxicity.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21574173      PMCID: PMC3166555          DOI: 10.1002/hep.24429

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Authors:  A Krug; S Rothenfusser; V Hornung; B Jahrsdörfer; S Blackwell; Z K Ballas; S Endres; A M Krieg; G Hartmann
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

Review 2.  Drug-induced hepatotoxicity.

Authors:  William M Lee
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

3.  The case for limiting acetaminophen-related deaths: smaller doses and unbundling the opioid-acetaminophen compounds.

Authors:  W M Lee
Journal:  Clin Pharmacol Ther       Date:  2010-09       Impact factor: 6.875

4.  Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.

Authors:  Cynthia Ju; Timothy P Reilly; Mohammed Bourdi; Michael F Radonovich; John N Brady; John W George; Lance R Pohl
Journal:  Chem Res Toxicol       Date:  2002-12       Impact factor: 3.739

5.  The hepatic inflammatory response after acetaminophen overdose: role of neutrophils.

Authors:  J A Lawson; A Farhood; R D Hopper; M L Bajt; H Jaeschke
Journal:  Toxicol Sci       Date:  2000-04       Impact factor: 4.849

6.  Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma.

Authors:  Hiroyuki Matsuda; Takafumi Suda; Hideo Hashizume; Koushi Yokomura; Kazuhiro Asada; Kenichiro Suzuki; Kingo Chida; Hirotoshi Nakamura
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

Review 7.  Sepsis syndromes: understanding the role of innate and acquired immunity.

Authors:  A Oberholzer; C Oberholzer; L L Moldawer
Journal:  Shock       Date:  2001-08       Impact factor: 3.454

8.  Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.

Authors:  George Miller; Venu G Pillarisetty; Alaap B Shah; Svenja Lahrs; Ronald P DeMatteo
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells.

Authors:  Kevin W Tinsley; Mitchell H Grayson; Paul E Swanson; Anne M Drewry; Katherine C Chang; Irene E Karl; Richard S Hotchkiss
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

10.  A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury.

Authors:  Yuko Ishida; Toshikazu Kondo; Tohru Ohshima; Hiromi Fujiwara; Yoichiro Iwakura; Naofumi Mukaida
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

View more
  27 in total

Review 1.  Immune mechanisms in acetaminophen-induced acute liver failure.

Authors:  Oliver Krenkel; Jana C Mossanen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

2.  Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury.

Authors:  Lyn M Wancket; Xiaomei Meng; Lynette K Rogers; Yusen Liu
Journal:  Toxicol Pathol       Date:  2012-05-23       Impact factor: 1.902

3.  Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.

Authors:  C David Williams; Mary Lynn Bajt; Matthew R Sharpe; Mitchell R McGill; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-15       Impact factor: 4.219

4.  Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.

Authors:  J Wang; X Cao; J Zhao; H Zhao; J Wei; Q Li; X Qi; Z Yang; L Wang; H Zhang; L Bai; Z Wu; L Zhao; Z Hong; Z Yin
Journal:  Clin Exp Immunol       Date:  2017-01-05       Impact factor: 4.330

5.  Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen.

Authors:  R D Fannin; K Gerrish; S O Sieber; P R Bushel; P B Watkins; R S Paules
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

6.  Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Authors:  Justin R Henning; Christopher S Graffeo; Adeel Rehman; Nina C Fallon; Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Mohsin Jamal; Michael Deutsch; Stephanie Greco; Melvin Ego-Osuala; Usama Bin-Saeed; Raghavendra S Rao; Sana Badar; Juan P Quesada; Devrim Acehan; George Miller
Journal:  Hepatology       Date:  2013-06-24       Impact factor: 17.425

7.  Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activation.

Authors:  Yuchao Xie; C David Williams; Mitchell R McGill; Margitta Lebofsky; Anup Ramachandran; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2012-09-17       Impact factor: 4.849

Review 8.  Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the Liver.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2015-05-19

9.  Regulation of alternative macrophage activation in the liver following acetaminophen intoxication by stem cell-derived tyrosine kinase.

Authors:  Carol R Gardner; Pamela Hankey; Vladimir Mishin; Mary Francis; Shan Yu; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-05-01       Impact factor: 4.219

10.  Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity.

Authors:  Michaël Maes; Mitchell R McGill; Tereza Cristina da Silva; Chloé Abels; Margitta Lebofsky; James L Weemhoff; Taynã Tiburcio; Isabel Veloso Alves Pereira; Joost Willebrords; Sara Crespo Yanguas; Anwar Farhood; Alain Beschin; Jo A Van Ginderachter; Silvia Penuela; Hartmut Jaeschke; Bruno Cogliati; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2016-11-08       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.